chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse concerning two patients of unknown age and gender. The patients' concurrent conditions and medical history were unspecified. On an unknown date, the patients were inadvertently vaccinated with VARIVAX (dose, route, Lot No. and expiration date were unspecified), instead of a dose of ZOSTAVAX. There was no concomitant medication described. No adverse effects were reported. It was unknown if the patient sought medical attention. There was not a product quality complaint involved. Additional information has been requested.
Right arm hurt upon receiving vaccination. I went to bed at 7:00p.m. Around 10:30 pm 4/12/2021, my husband came in to check on me because I was moaning and crying in my sleep. My head/brain hurt HORRIBLY inside and to the touch. I proceeded to take tylenol.  On 4/13/21, around 9:30 p.m., I was sitting in my chair. I rose to put a dish in the sink. My vision became blurry and I fainted/blacked out. I hit my head, back, and left hip. I was able to crawl to my iwatch and called my husband who was asleep. He helped me to my chair. I have a bump/lump on my head still and it still hurts. Up until yesterday, 4/19/21, I was achy all over and my head still hurt
Pt. thought felt itchy after giving but also said that sometimes has reaction to adhesive so removed BANDAID. Before pt. left after waiting a while to leave pts. redness seemed gone. Pt. came back in on 6/25/17 after going to Urgent Care because had circular itchy rash around injection site.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and demographics. The patient's concurrent conditions and medical history was not provided. On 21-APR-2015, the patients was vaccinated with (Oka/Merck) VARIVAX lot # J003541, that had expired on 25-MAR-2015, 0.5 ml, subcutaneous. No adverse experience reported. No product quality complaint reported. Additional information has been requested.
Information has been received from a physician (a counselor reported it to the physician) concerning unspecified number of patients who were vaccinated with a dose of GARDASIL vaccine (yeast). Subsequently the patients experienced moodiness. The counselor stated that she felt mood problems were probably related to the vaccination as she had seen similar reactions in other clinics. This is one of several reports from the same source. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
Patient is under 18 years old (15 years old) and was given Moderna booster instead of Pfizer  despite reviewing the consent form. Noticed the error  when patient and parents were still in the Pharmacy waiting after vaccination.  Patient and guardian were informed about the situation. Parents were not concerned. They would rather have him get a booster than not.   Pharmacist checked up on the Patient the next day (12/23/2021), the patient is doing fine and is not experiencing any adverse events other than sore arm.  We further recommended to still observe for any symptoms that might show up on the upcoming days and advised them to let us know .
Next morning had fever 101.5 joint aches nausea and felt like, "half of me is here, half somewhere else."  Feeling very sleepy, sleeping more than usual.  Feeling short of breath and coughing, "old asthma acting up."  Tightness and discomfort in chest.  Symptoms slowly resolving.
I started off with cold and flu symptoms and first few days I really believed it was a  cold then I started having a fever so I went in got a covid test it came back positive, I kept running fevers at 102.5 . I went in for a chest x-ray, they put me on antibiotic for double pneumonia, Then I went in for monoclonal antibodies, I had covid Pneumonia from the 24th to the 5th . I feel like I'm about 85% back, I definitely still have chest congestion.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Has not received dose two; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received in 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.     Additional Information: GSK receipt date: 10-Aug-2022 Reporter comment: The pharmacist reported that patient received first dose of Shingrix and had not received second dose. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
throat tickling; knee pain; slight back pain; This case was reported by a consumer via call center representative and described the occurrence of throat irritation in a 64-year-old male patient who received Rabies NVS (RabAvert) for prophylaxis.   The patient's past medical history included animal bite. Previously administered products included Rabavert with an associated reaction of arthralgia (1st dose received on unknown, please refer the case US2020146787), Rabavert with an associated reaction of arthralgia (2nd dose received on unknown, please refer the case US2020AMR148390), Rabavert with an associated reaction of arthralgia (3rd dose received on unknown, please refer the case US2020AMR148391) and Rabavert with an associated reaction of arthralgia (4th dose received on unknown, please refer the case US2020AMR148392). Concurrent medical conditions included diabetes. Concomitant products included warfarin, immunoglobulin human normal (Gamma Globulin), paracetamol (Tylenol) and benadryl (nos) (Benadryl).   On an unknown date, the patient received the 5th dose of RabAvert. On an unknown date, unknown after receiving RabAvert, the patient experienced throat irritation, knee pain and back pain. On an unknown date, the outcome of the throat irritation was recovered/resolved and the outcome of the knee pain and back pain were not recovered/not resolved.   It was unknown if the reporter considered the throat irritation, knee pain and back pain to be related to RabAvert.  Additional case details were reported as follows: The age at vaccination was not reported. The reporter stated with every Rabavert shot he experiences throat tickling which goes away after a day.  The patient experienced ongoing knee pain and ongoing slight back pain.  The reporter consent to follow up. This is 5 of 5 case reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR148390:
Pt developed body aches, fatigue, fever, chills, mild headaches and was light-head. He is currently taking 20mg of Prednisone. On-going.
intense/immediate hives randomly throughout the body with severe itching sometimes with fields of red raised patches. At times, my hands and feet are involved. I also experience this at the injection site.I get moderate relief with Zyrtec, which only lasts about halfway through the 24 hour dose period. This reaction was not present at my 1st and 2nd dose. It should be noted that with each dose, I have experienced flu like symptoms severe enough to make me bedridden for 2-3 days. Since dose 1, these flu like symptoms reappear every 2-3 weeks.
Child is 11 years 10 months of age. MD ordered DTaP and nurse gave DTaP instead of the TDaP.
2nd dose of the COVID-vaccine administered on the morning of 2/18/21.  Within the hour after administration, severe pain on left shoulder (site of administration) was experienced.  Swelling, consistent aching pain, and limited range of motion/inability to lift arm over her head.  Motrin for 2 days was self administered with improvement in severity of pain but recurred when Motrin discontinued.  Motrin was taken as needed thereafter and was the pain continued until 2/26.  Employee was followed up on 3/10 and verbalized that the pain had fully resolved. No further interventions.
I have rheumatoid arthritis which is in remission; high blood pressure; my BP & O2 level bottomed out on me; my BP & O2 level bottomed out on me; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHEUMATOID ARTHRITIS (medically significant), outcome "unknown", described as "I have rheumatoid arthritis which is in remission"; HYPERTENSION (non-serious), outcome "unknown", described as "high blood pressure"; BLOOD PRESSURE ABNORMAL (non-serious), OXYGEN SATURATION ABNORMAL (non-serious), outcome "unknown" and all described as "my BP & O2 level bottomed out on me". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: high; Unknown results, notes: My BP and O2 level bottomed on me; Oxygen saturation: Unknown results, notes: My BP and O2 level bottomed on me.  Clinical course: The reporter reported that, patient will be 70 in November. Patient just got over the covid. Patient was fully vaccinated & continued to wear my mask & etc. The patient was very thankful for the vaccines & the antiviral made by Pfizer and doing fine now.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax 515PM;523Pm had swollen rt eye, running nose BP 140/90, R 20, P80;DPH given immed transferred to ER;
lower back pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (lower back pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (lower back pain). At the time of the report, BACK PAIN (lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
Brain fog along with cognitive issues also Blurry vision. Right leg tremors which now has progressed to whole body tremors. Right hip pain sever and mild left side hip pain. Hand swelling along with neck and back pain which has professed to joint pain threw out body . Right sided weakness and lose of balance. Sleeping issues .
Patient received Moderna COVID vaccine on 1/19/21 (lot # 037K20A), 2/17/21 (lot # 024M20A), and 12/6/21 (lot # 030H21B). On 8/12/22, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia and sepsis secondary to COVID19 pneumonia. Patient transferred on 8/18/22 for rescue BIPAP and as of today (8/19/22), patient is still admitted.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 9:04 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 9:04 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 45.72 for dose administered on 3-Apr-2021 No concomitant medications were reported. Batch number 030B21A underwent temperature excursion on 3-Apr-2021 with temperature 34 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 3-Apr-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported
Chicken Pox breakthrough on 4/04 in trunk area, neck, Rt thigh- Had Varivax noted 2/10/1998
His mom states it started out as 5-6 bumps around injection site and progressed to neck and face.
Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient was given flu vaccine. Patient came to counter to get vaccine record. Said felt dizzy and fainted abruptly. Was breathing and somewhat responsive. Fully responsive and coherent when paramedics arrived. Paramedics checked all vitals outside the target store. Mom and patient came back all well. Mom was going to take son to ER just to check head ok.
Initial information received from a consumer on 09 Jul 2010: This patient received the first dose of RABAVERT (batch number: 426011A, expiry date: not provided), intramuscular on 22 Jun 2010. The patient developed nausea, vomiting and loss of appetite on 23 Jun 2010. The patient received the second dose of RABAVERT on 29 Jun 2010. On an unknown date after second dose the symptoms was worsened. The patient was visited to clinic, and was found to have enlarged liver, hepatitis and liver enzymes aspartate aminotransferase (ASR) and alanine aminotransferase (ALT) were raised 15 times than normal limit. The outcome of the events reported was condition unchanged.
Child had seizures, mother reported child stopped breathing. Taken to ER; child doing o.k. at this time.
p/vax pt exp soreness of the arm;pt also exp a high fever 103 in the evening, also hallucinatory dreams & delirium;got up & wandered the house w/the dreams & was diff to awaken;APAP given;pt exp mottled rash, t101, lethargic & n;
No adverse event; patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.; patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.) and NO ADVERSE EVENT (No adverse event) in a 2-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Aug-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2022, the patient experienced ACCIDENTAL UNDERDOSE (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for ACCIDENTAL UNDERDOSE (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg.).    No concomitant medications was reported. No treatment medications was reported.  The patient pulled away from the 2nd dose of the Moderna Covid-19 vaccine and most of the dose leaked down the patients leg. the patient received the vaccine in the left thigh. No other adverse reactions were reported.
I woke late in the morning and it felt like I was spinning. It was bad enough to where I could not move. I called my doctor and they asked me to come in. I couldn't drive or get help so I looked online for a home remedy. Found that strawberries help and started eating them. Worked just fine and I was able to do things again. I have my strawberries everyday and I have yet to have another episode.
Severe headache 1st day post vaccination, moderate headache 2nd day post vaccination.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Apr2021 14:15 (Lot number: ew0161) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hypertriglyceridemia" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "degenerated discs" (unspecified if ongoing); "known allergies: whey" (unspecified if ongoing); "known allergies: pineapple, banana" (unspecified if ongoing); "known allergies: asparagus" (unspecified if ongoing); "known allergies: pollen" (unspecified if ongoing); "known allergies: mold" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SUDAFED 12 HOUR; FENOFIBRIC ACID. Past drug history included: Amoxicillin, reaction(s): "known allergies: amoxicillin: rash as infant"; Ondansetron, reaction(s): "Known allergies: ondansetron: facial swelling"; Ondansetron, reaction(s): "Known allergies: ondansetron: digestive issues"; Ondansetron, reaction(s): "Known allergies: ondansetron: stuffy nose"; Ondansetron, reaction(s): "Known allergies: ondansetron: migraine". The following information was reported: HEADACHE (non-serious) with onset 13Apr2021, outcome "unknown", described as "Severe headache 1st day post vaccination, moderate headache 2nd day post vaccination.". Therapeutic measures were not taken as a result of headache.  Additional Information: The patient reported that, first day she did not work, second day reduced work hours. Prior vaccination she never had Covid and post vaccination she was not tested for Covid.  No follow-up attempts are possible. No further information is expected.
After administration of 1st covid vaccine, pt immediatly felt a pull/pain in her right leg. Left leg pain continued for 2 weeks. Pt went to doctor, and diagnosed her with superficial phelbitis and was given ^600 mg Ibuprofen for pain. Ibuprofen did not help, only icy hot relieves pain.  Deffered pt to wait to get second dose until leg pain has subsided.
pt recv vax 19NOV96 & 21NOV96 it was reported that pt had devel Bells Palsy;
Within a minute or two of receiving the vaccine started to experience chest tightness and was feeling a wave of getting hot. Does not have a hx of anxiety.
shaking in her hands that felt like she is nervous; shaking in her hands that felt like she is nervous; She also experience some hard tingling on her right ankle.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 27Jul2021 (Batch/Lot number: not reported) (at the age of 59-years-old) as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 27Jul2021, the patient experienced shaking in her hands that felt like she was nervous and also similar to that when she had a coffee. She also experienced some hard tingling on her right ankle. As of the moment, she had calmed down and had been okay. The outcome of the events was recovered in 2021.  Information on the lot/batch number has been requested.
Pt calling to state she developed nausea and vomiting with diarrhea yesterday and wonders if this is linked to her Tdap injection she received yesterday.  Pt denies fever, dizziness, visual problems or any other sx.  Pt denies any redness or swelling at the injection site.  Pt states she will increase fluids and monitor sx.  Pt will see medical treatment if sx worsen.  Pt aware we will call tomorrow to check on her sx.  Notified of possible rxn to Adacel vs stomach flu.
Janssen COVID-19 Vaccine EUA  The vaccine was administered Friday 12th at 1:30 pm   Saturday morning, the13th - there was loss of appetite Saturday 5:00 pm - fever of 102.0  was recorded.  Administered 2 Tylenol and fever reduced slowly over the next 5-6 hours. Sunday 14th - no apparent symptoms
Pt recvd 3 doses of Engerix-B vax 1NOV90, 4DEC90, & 1MAY91 & 9SEP91 it was determined that pts titer was neg p/3 doses of Engerix-B;